Health establishments send their referring blood establishment the information mentioned in II of article R. 1221-36 and in 2° of article R. 1221-37.
Decisions by the Director General of the Agence nationale de sécurité du médicament et des produits de santé (French Agency for the Safety of Medicines and Health Products) taken after consultation with the Etablissement français du sang (French Blood Establishment) and the Armed Forces Blood Transfusion Centre may specify the content of the information mentioned in this article and lay down the procedures for its collection by the blood establishment or its transmission by the health establishments.